Please login to the form below

Not currently logged in
Email:
Password:

Kite Pharma names Cynthia Butitta as CFO

She helped broker Pfizer’s takeover of NextWave Pharmaceuticals

Kite Pharma has named industry veteran Cynthia Butitta as chief financial officer.

Butitta was most recently chief financial officer of NextWave Pharmaceuticals and played a key role in the company's acquisition by Pfizer in October 2012.

Her other previous roles include chief financial officer and chief operating officer of Telik where she was responsible for securing over $450m through an initial public offering (IPO). She was also VP of finance at the biotech Connetics.

Kite Pharma is a biotech specialist in the burgeoning area of cancer immunotherapy products.

It has made a number of recent senior appointments in recent months – including several immunotherapy experts to its scientific advisory board and a chief medical officer – and Butitta is the latest hire to bolster its senior team.

“As a leading company in the emerging and highly promising field of immunotherapy, Kite has the opportunity to play a pivotal role in changing the way we approach cancer,” said Butitta.

10th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics